Current approach to relapsed acute lymphoblastic leukemia in children

doi:10.5315/wjh.v3.i3.49

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (18871)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

1695

WORD

444

HTML

12494

Figures (1-1)

246

Tables (1-6)

330

Sum=15209

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

604

Download

1017

Sum=1621

Publishing Process of This Article

Item

Count

Browse

1011

Download

1030

Sum=2041

Aug 6, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Aug 6, 2014; 3(3): 49-70
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.49

Open in New Tab Full Size Figure Download Figure

Figure 1 Algorithm for the management of relapsed acute lymphoblastic leukaemia in children. Risk allocation is based on immunophenotype, time and site of relapse (see Table 5). SCT: Allogeneic stem cell transplantation; MRD: Minimal residual disease.

Citation: Fuster JL. Current approach to relapsed acute lymphoblastic leukemia in children. World J Hematol 2014; 3(3): 49-70
URL: https://www.wjgnet.com/2218-6204/full/v3/i3/49.htm
DOI: https://dx.doi.org/10.5315/wjh.v3.i3.49